Showing results (291-300 of 316) with videos related to
Sort By:
Pageof 32
International Urology and Nephrology|November 8, 2024
Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group)Yuki Yokoyama, Makoto Kawase, Shin Ebara, et al.Oncotarget|March 2, 2018
Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinomaHirotaka Horiguchi, Shingo Hatakeyama, Go Anan, et al.Biomedicines|September 23, 2022
Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort StudyToyohiro Yamada, Keita Nakane, Torai Enomoto, et al.Cancers|December 11, 2022
Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group)Sanae Namiki, Makoto Kawase, Shin Ebara, et al.Medical Oncology (Northwood, London, England)|April 12, 2017
Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancerAyumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, et al.Journal of Clinical Medicine|December 23, 2023
The Negative Impact of Inflammation-Related Parameters in Prostate Cancer after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group)Kazumasa Murase, Makoto Kawase, Shin Ebara, et al.Cancer Medicine|March 21, 2017
Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumorsTakuma Narita, Shingo Hatakeyama, Tohru Yoneyama, et al.Clinical Genitourinary Cancer|June 30, 2022
Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)Yusuke Sugino, Takeshi Sasaki, Shin Ebara, et al.Biomedicines|July 27, 2022
The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial CarcinomaRisa Tomioka-Inagawa, Keita Nakane, Torai Enomoto, et al.Cancer Science|May 31, 2019
Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detectionTohru Yoneyama, Yuki Tobisawa, Tomonori Kaneko, et al.Pageof 32